IN THE PRESS
Quoted in Women’s Health: GLP-1 Drugs May Have Another Potential Benefit for Migraine
Women's Health MagazineDr. Suraj Malhan was quoted in Women’s Health discussing emerging research on GLP-1 receptor agonists and migraine.
An emerging study analyzing nearly 22,000 patients with chronic migraine found that GLP-1 receptor agonists were associated with fewer emergency visits, hospitalizations, and escalation to additional preventive medications compared with topiramate. The findings highlight a potential connection between metabolic pathways and migraine and suggest an important area for future research.
Read More:
https://www.womenshealthmag.com/health/a70626520/glp-1-drugs-migraine-severity-study/